Atai Life Sciences, a biopharmaceutical company traded as ATAI on Nasdaq, announced a Bitcoin treasury strategy, starting with a $5 million investment. The founder highlighted Bitcoin's properties as essential for treasury strategies, especially for biotech companies facing financial risks.
The Celestia fire sparked widespread discussion about modular blockchains. In fact, modular blockchain has always been an important part of the application chain narrative and is not a new thing.
